Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

Ossama A Ahmed,1 Hany H Kaisar,1 Rehab Badawi,2 Nehad Hawash,2 Hossam Samir,1 Sherif ST Shabana,1 Mohamed Hassan A Fouad,1 Fatma H Rizk,3 Samy A Khodeir,4 Sherief Abd-Elsalam2 1Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 2Department of Tropical Medicine...

Full description

Bibliographic Details
Main Authors: Ahmed OA, Kaisar HH, Badawi R, Hawash N, Samir H, Shabana SST, Fouad MHA, Rizk FH, Khodeir SA, Abd-Elsalam S
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Infection and Drug Resistance
Subjects:
HCV
treatment
Egypt
sofosbuvir
ledipasvir
Harvoni.
Online Access:https://www.dovepress.com/efficacy-and-safety-of-sofosbuvir-ledipasvir-for-treatment-of-a-cohort-peer-reviewed-article-IDR

Internet

https://www.dovepress.com/efficacy-and-safety-of-sofosbuvir-ledipasvir-for-treatment-of-a-cohort-peer-reviewed-article-IDR

Similar Items